RCT with 157 patients treated with honey and nigella sativa, and 156 control patients, showing significantly faster recovery and viral clearance.
Ashraf et al., 11/3/2020, Randomized Controlled Trial, Pakistan, South Asia, preprint, 48 authors, this trial uses multiple treatments in the treatment arm (combined with honey) - results of individual treatments may vary.
risk of death, 81.9% lower, RR 0.18, p = 0.01, treatment 2 of 157 (1.3%), control 11 of 156 (7.1%), all cases.
risk of death, 67.1% lower, RR 0.33, p = 0.49, treatment 0 of 107 (0.0%), control 1 of 103 (1.0%), continuity correction due to zero event (with reciprocal of the contrasting arm), moderate cases.
risk of death, 78.8% lower, RR 0.21, p = 0.03, treatment 2 of 50 (4.0%), control 10 of 53 (18.9%), severe cases.
risk of no recovery, 83.6% lower, RR 0.16, p < 0.001, treatment 107, control 103, moderate cases.
risk of no recovery, 75.2% lower, RR 0.25, p < 0.001, treatment 50, control 53, severe cases.
risk of no virological cure, 81.9% lower, RR 0.18, p < 0.001, treatment 107, control 103, moderate cases.
risk of no virological cure, 76.9% lower, RR 0.23, p < 0.001, treatment 50, control 53, severe cases.